The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 1986-10, Vol.54 (4), p.705-709 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 709 |
|---|---|
| container_issue | 4 |
| container_start_page | 705 |
| container_title | British journal of cancer |
| container_volume | 54 |
| creator | Sheard, C R Reilly, F Tee, D E Vergani, D Lowe, D Baum, M Cameron, A E |
| description | |
| doi_str_mv | 10.1038/bjc.1986.230 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2001508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3490874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-26ddd2e34fb9e6955e3496843a3d7876567503694055acf8fcfc940be9ce07263</originalsourceid><addsrcrecordid>eNptkM9r2zAUx8VoybJut10LOvQ4p8-WLcuXQgndOha6S3YWsvyUOLUlIzlh-e8rkxBW2Env8b4_xIeQryksUmDivt7pRVoJvsgYfCDztGBZkoqsvCJzACgTqDL4SD6FsItrBaKckRnLpyGfk3G9RYrGoB6pM1Q1u_1B2ZHqo-7csHVh2Kq-bZA6T0fVu7-tQUudpWP02X1fow-TsTv2Ua2PIwZao_Kt3dA11dh1k_Pl12nslX-Nhs_k2qgu4Jfze0P-fH9aL5-T1e8fP5ePq0TnOR-TjDdNkyHLTV0hr4oijhUXOVOsKUXJC14WwHiVQ1EobYTRRselxkojlBlnN-ThlDvs6x4bjXb0qpODb-NHjtKpVr6_2HYrN-4gM4C0ABEDvp0CtHcheDQXbwpygi8jfDnBlxF-lN_-23cRn2nH-935roJWnfHK6jZcZAJSLsqpNTnJwjBxRC93bu9tJPX_2jfB153q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers</title><source>MEDLINE</source><source>Nature Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Sheard, C R ; Reilly, F ; Tee, D E ; Vergani, D ; Lowe, D ; Baum, M ; Cameron, A E</creator><creatorcontrib>Sheard, C R ; Reilly, F ; Tee, D E ; Vergani, D ; Lowe, D ; Baum, M ; Cameron, A E</creatorcontrib><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1986.230</identifier><identifier>PMID: 3490874</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Breast Neoplasms - blood ; Breast Neoplasms - drug therapy ; Cancer Research ; Chemotherapy ; Cyclophosphamide - therapeutic use ; Drug Resistance ; Epidemiology ; Female ; Humans ; Killer Cells, Natural - drug effects ; Leukocyte Count ; Medical sciences ; Molecular Medicine ; Oncology ; Pharmacology. Drug treatments ; short-communication ; T-Lymphocytes - drug effects ; Tamoxifen - therapeutic use</subject><ispartof>British journal of cancer, 1986-10, Vol.54 (4), p.705-709</ispartof><rights>Cancer Research Campaign 1986</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-26ddd2e34fb9e6955e3496843a3d7876567503694055acf8fcfc940be9ce07263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001508/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001508/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8016878$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3490874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheard, C R</creatorcontrib><creatorcontrib>Reilly, F</creatorcontrib><creatorcontrib>Tee, D E</creatorcontrib><creatorcontrib>Vergani, D</creatorcontrib><creatorcontrib>Lowe, D</creatorcontrib><creatorcontrib>Baum, M</creatorcontrib><creatorcontrib>Cameron, A E</creatorcontrib><title>The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Breast Neoplasms - blood</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Cancer Research</subject><subject>Chemotherapy</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Killer Cells, Natural - drug effects</subject><subject>Leukocyte Count</subject><subject>Medical sciences</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Pharmacology. Drug treatments</subject><subject>short-communication</subject><subject>T-Lymphocytes - drug effects</subject><subject>Tamoxifen - therapeutic use</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkM9r2zAUx8VoybJut10LOvQ4p8-WLcuXQgndOha6S3YWsvyUOLUlIzlh-e8rkxBW2Env8b4_xIeQryksUmDivt7pRVoJvsgYfCDztGBZkoqsvCJzACgTqDL4SD6FsItrBaKckRnLpyGfk3G9RYrGoB6pM1Q1u_1B2ZHqo-7csHVh2Kq-bZA6T0fVu7-tQUudpWP02X1fow-TsTv2Ua2PIwZao_Kt3dA11dh1k_Pl12nslX-Nhs_k2qgu4Jfze0P-fH9aL5-T1e8fP5ePq0TnOR-TjDdNkyHLTV0hr4oijhUXOVOsKUXJC14WwHiVQ1EobYTRRselxkojlBlnN-ThlDvs6x4bjXb0qpODb-NHjtKpVr6_2HYrN-4gM4C0ABEDvp0CtHcheDQXbwpygi8jfDnBlxF-lN_-23cRn2nH-935roJWnfHK6jZcZAJSLsqpNTnJwjBxRC93bu9tJPX_2jfB153q</recordid><startdate>19861001</startdate><enddate>19861001</enddate><creator>Sheard, C R</creator><creator>Reilly, F</creator><creator>Tee, D E</creator><creator>Vergani, D</creator><creator>Lowe, D</creator><creator>Baum, M</creator><creator>Cameron, A E</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>19861001</creationdate><title>The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers</title><author>Sheard, C R ; Reilly, F ; Tee, D E ; Vergani, D ; Lowe, D ; Baum, M ; Cameron, A E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-26ddd2e34fb9e6955e3496843a3d7876567503694055acf8fcfc940be9ce07263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Breast Neoplasms - blood</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Cancer Research</topic><topic>Chemotherapy</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Killer Cells, Natural - drug effects</topic><topic>Leukocyte Count</topic><topic>Medical sciences</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Pharmacology. Drug treatments</topic><topic>short-communication</topic><topic>T-Lymphocytes - drug effects</topic><topic>Tamoxifen - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheard, C R</creatorcontrib><creatorcontrib>Reilly, F</creatorcontrib><creatorcontrib>Tee, D E</creatorcontrib><creatorcontrib>Vergani, D</creatorcontrib><creatorcontrib>Lowe, D</creatorcontrib><creatorcontrib>Baum, M</creatorcontrib><creatorcontrib>Cameron, A E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheard, C R</au><au>Reilly, F</au><au>Tee, D E</au><au>Vergani, D</au><au>Lowe, D</au><au>Baum, M</au><au>Cameron, A E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1986-10-01</date><risdate>1986</risdate><volume>54</volume><issue>4</issue><spage>705</spage><epage>709</epage><pages>705-709</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>3490874</pmid><doi>10.1038/bjc.1986.230</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 1986-10, Vol.54 (4), p.705-709 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2001508 |
| source | MEDLINE; Nature Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Antineoplastic agents Biological and medical sciences Biomedical and Life Sciences Biomedicine Breast Neoplasms - blood Breast Neoplasms - drug therapy Cancer Research Chemotherapy Cyclophosphamide - therapeutic use Drug Resistance Epidemiology Female Humans Killer Cells, Natural - drug effects Leukocyte Count Medical sciences Molecular Medicine Oncology Pharmacology. Drug treatments short-communication T-Lymphocytes - drug effects Tamoxifen - therapeutic use |
| title | The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A17%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20adjuvant%20cyclophosphamide%20or%20tamoxifen%20on%20the%20numbers%20of%20lymphocytes%20bearing%20T%20cell%20or%20NK%20cell%20markers&rft.jtitle=British%20journal%20of%20cancer&rft.au=Sheard,%20C%20R&rft.date=1986-10-01&rft.volume=54&rft.issue=4&rft.spage=705&rft.epage=709&rft.pages=705-709&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1986.230&rft_dat=%3Cpubmed_cross%3E3490874%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3490874&rfr_iscdi=true |